Reproductive function in a human being consists of continuous hormonal changes in the female. These hormonal changes are responsible for dynamic changes occurring in the ovarian and uterine morphology and vascularity. Ultrasound and Doppler are very useful modalities for assessing these changes, and therefore, very effective for diagnosis of hormonal derangements and monitoring the assisted reproductive technology (ART) treated cycles. Among the common hormones that need to be assessed, androgen can be correlated with high antral follicle count (AFC) and high uterine artery resistance and anti-Müllerian hormone (AMH) also has a positive correlation with AFC. Follicle-stimulating hormone (FSH) is reflected as follicular growth, and luteinizing hormone (LH) by ovarian stromal echogenicity and vascularity and endometrial hyperechogenicity. Estrogen adequacy can be judged by follicular and endometrial flow in preovulatory phase whereas progesterone adequacy can be judged by corpus luteal and endometrial flow in mid luteal phase. Day-to-day hormonal assessment can therefore be replaced by ultrasound and Doppler during ART.
INTRODUCTION
Reproductive function in a human being consists of continuous hormonal changes in the female. These hormonal changes are responsible for dynamic changes occurring in the ovarian and uterine morphology and vascularity. These morphological and vascular changes can be best studied by transvaginal ultrasound and Doppler. Correlating the morphological and vascular changes with their physiological and hormonal basis can be a helpful way to understand the hormonal changes occurring during the menstrual cycle whether natural or stimulated. These changes can be monitored by different imaging modalities.
Imaging modalities that can study the morphological and vascular changes of ovary, endometrium, and uterus are ultrasound and Doppler. Soon after the ultrasound was used for antenatal scanning, it was also used to assess the nonpregnant uterus and ovaries. Transabdominal ultrasound was the approach used earlier but this approach has certain inherent disadvantages. It uses a lowfrequency probe that has a low resolution. Moreover, the probe is placed far from the pelvic organs, which further reduces the precision of information available on scan. Apart from this, the full bladder that patient requires to hold is also a discomfort.
With the development of endocavity probes, transvaginal route became very popular for scanning the pelvic organs, uterus, ovaries, and fallopian tubes. It uses a highfrequency probe, and the probe is placed very close to the uterus and ovaries, both help to achieve high-resolution images of uterus and ovaries. The resolution was further improved in high-end scanners by advanced features that are used to improve the b mode image. These are harmonics, speckle reduction imaging, and compound resolution imaging. All these together made it possible to assess morphology of uterus and ovaries more precisely. Improvement in the Doppler sensitivity with advancing technology made it possible to assess the blood flow changes in small blood vessels of ovarian stroma, follicle, and endometrium. Volume ultrasound further leads to assessment of global vascularity of ovary, follicle, and endometrium. Moreover, these volume studies are also used to assess the volumes of the organs or structures instead of just diameters. Magnetic resonance imaging (MRI) though allows detailed morphological assessment, but is less patient-friendly and more expensive than ultrasound. The greater disadvantage of MRI is that it is not a dynamic examination and also cannot be repeatedly done to observe day-to-day changes. This disadvantage can be over powered by volume ultrasound and also by the real-time studies that are possible by ultrasound and not by MRI.
Ultrasound has been widely used for the assessment of pathologies of uterus, fallopian tubes, and ovaries. But here, we shall discuss its role for understanding the physiology, in assessment and monitoring of natural and DSJUOG stimulated menstrual cycles respectively, and will try to understand and correlate the hormonal changes with the ultrasound findings of ovaries and uterus in different phases of menstrual cycle.
The hormones that play a major role in the reproductive physiology are:
• Androgen • Anti-Müllerian hormone (AMH) • Follicle-stimulating hormone (FSH) • Luteinizing hormone (LH) • Estrogen • Progesterone.
ANDROGEN
The menstrual cycle starts on first day of the menstruation. But actually the recruitment of the follicles from preantral to antral follicles starts in the late luteal phase of the previous cycle. The antral follicles are 2 mm and more in size and are then recognizable by ultrasound. Recruitment of these follicles is a function of androgen, and antral follicle count (AFC) represents the functional ovarian reserve. Higher androgen level would lead to more follicles being converted from preantral to antral, and so higher AFC. 1 It is for this reason that patients with polycystic ovary syndrome (PCOS), who have hyperandrogenemia, show higher AFC as compared with controls ( Figs 1A and B) . Obesity and insulin resistance may enhance follicular excess by dysregulation of AMH through pathway of hyperandrogenemia.
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Antral follicle count and ovarian volume showed significant correlation with AMH, total testosterone, and free androgen index. 2 Hyperinsulinemic PCOS patients had an increased vascularity of the ovarian stroma. 3 Increased ovarian stromal blood flow in PCOS may be because of over expression of vascular endothelial growth factor, which modulates the permeability of theca cells and increase insulin-like growth factor 1. 4, 5 This in turn enhances gonadotropin-stimulated steroid production in granulosa cells and theca cells, resulting in increased ovarian androgen production and subsequently increased AMH. 6 Moreover, androgen is responsible for smooth muscle tone. Uterine arteries have thick muscularis layer to allow the flexibility and dynamicity in its caliber during different phases of menstruation and also during pregnancy and labor. This layer consists of smooth muscle fibers and therefore androgen leads to increased tone in these muscles and therefore high resistance flow in uterine arteries in PCOS patients, during the whole cycle (Fig. 2) . 7 The ovarian stroma/total ovarian volume ratio was the most accurate predictor of both hyperandrogenemia (area under the curve, 0.915; p < 0.0001) and hirsutism (area under the curve, 0.891; p < 0.0001). 
ANTI-MÜLLERIAN HORMONE
Biochemically ovarian reserve can be assessed by AMH, FSH, and inhibin B.
Anti-Müllerian hormone is produced by granulosa cells of preantral and small antral follicles of between 2 and 6 mm, before they become sensitive to FSH. It is a regulator of recruitment of follicles. Anti-Müllerian hormone has an advantage that it can be in any phase of cycle, though threshold in both phases may be different.
We have been all relating AFCs to AMH. But it is worth keeping in mind that androgen is the cause for the recruitment of the antral follicles and AMH is a result of recruited antral follicles. Antral follicle count and ovarian volume showed significant correlation with AMH.
The number of small antral follicles (2-6 mm) is significantly related to age and also, independent of age, to all endocrine ovarian reserve tests (ORTs), suggesting the number of small antral follicles represents the functional ovarian reserve. 9 Several studies have shown that AMH and AFC are both almost equally accurate tests for assessment of ovarian reserve. Antral follicle count and ovarian volume provide direct measurements of ovarian reserve, while AMH, inhibin B, and estradiol are released from growing follicles and so their levels reflect the size of developing follicle cohort. 10 Serum AMH levels have been shown to strongly correlate with the number of antral follicles 11, 12 and have appeared to be cycle independent. 13 16 Small AFC and AMH have similar predictive accuracy for high ovarian response with area under curve of 0.961 and 0.922 respectively. The sensitivity and specificity for prediction of high ovarian response were 89 and 92% for small AFC and 93 and 78% for AMH at the cutoff values of ≥16 and ≥34.5 pmol/L respectively. 17 In our study we compared the efficacy of AFC and AMH in PCO and non-PCO group. The results showed correlation of AFC and follicles >12 mm on day of human chorionic gonadotropin (hCG) in PCO group was 0.56 and non-PCO group was 0.63 and for AMH and follicles >12 mm on day of hCG in PCO group was 0.42, and non-PCO group was 0.47. Correlation of AFC with number of ova retrieved on OPU in PCO group is 0.44 and for non-PCO group is 0.50. The value for AMH is 0.39 in PCO and 0.43 for non-PCO group.
(Significance of correlation at 0.01 level is required to be higher than 0.283).
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In a meta-analysis by Broer et al, 19 it has been shown that AMH has at least the same level of accuracy and clinical value for the prediction of poor response and nonpregnancy as AFC. Anti-Müllerian hormone can be closely correlated with AFC ( Fig. 3 ) and can also be used as a test for ovarian reserve instead of AMH, without compromising the accuracy and efficacy.
FOLLICLE-STIMULATING HORMONE
Follicle-stimulating hormone is produced by pituitary and its secretion is controlled by the negative feedback of estrogen and also acts on granulosa cells to produce estrogen. In the initial phases of the menstrual cycle, the estrogen level is low, the FSH level is a little high, whereas in the preovulatory phase, the estrogen level rises and there is a fall in the FSH level. When the follicle size is less than 6 mm, these follicles are FSH independent. At a size of 6 to 9 mm, these become FSH sensitive by the development of FSH receptors, and beyond 9 mm these follicles are FSH dependent (Fig. 4) . Anti-Müllerian hormone, a product of preantral and small antral follicles, inhibits factors affecting FSH sensitivity of the follicle. As AMH levels decrease with follicle growth, this inhibition would be removed. 20 This means that the follicular growth beyond 6 mm size suggests FSH action. Therefore, faster growth of the follicles indicates high FSH. If this growth is fast in early follicular phase, it indicates high basal FSH. Early follicular recruitment-follicle of larger than 10 mm on the baseline scan indicates high basal FSH levels. But it is important to remember that the follicle that is, recruited early may grow fast on stimulation, but is less likely to produce good quality follicle due to its shorter duration to maturity.
Similarly, in stimulated cycle, too high doses of FSH may lead to faster follicular growth than normal which is 2 to 3 mm/day. This is not an advantage again as the ovum maturity may lag behind the size of the follicle in these cases; moreover, endometrial growth also may not cope up with this growth in follicular size.
Whereas a slow follicular growth rate indicates that the FSH level is lower than optimum. This is the situation in POCS patients. Because of multiple follicular development and aromatization of excess androgen to estrogen, there is rise in estrogen level leading to initiation of negative feedback to FSH, slow rise in FSH, and therefore, slow growth of follicles.
Follicle-stimulating hormone dynamics can be represented by ultrasound findings as follows:
High basal FSH -early recruitment of follicle (Fig. 5 ).
High doses of FSH -faster growth of the follicle than normal.
Slow rise in FSH or FSH of inadequate bioactivity (which is the case in aging ovaries): Slow growth rate of follicle. 
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LUTEINIZING HORMONE
Luteinizing hormone is also produced by pituitary. It is controlled by positive feedback of estrogen and acts on theca cells to produce progesterone from cholesterol. Luteinizing hormone is also responsible for proliferation of theca cells.
Elevated LH levels may be responsible for increased stromal vascularization due to neoangiogenesis, catecholaminergic stimulation, and leukocyte and cytokine activation. This means LH is responsible for stromal vascularity. 21 This is the reason why PCOS patients have increased stromal vascularity as compared with the normal controls.
The vascular parameters of the ovarian stromal vessels in PCOS and normal patients are as follows 22 
What Is the Effect of High LH in PCOS?
It is known that PCOS is not a cause but a result of chronic anovulation. It is a process of evolution from adolescent aged multicystic ovaries to polycystic ovaries. As a result of marginally high androgen levels in early follicular phase in polycystic ovarian disease patients, there is recruitment of multiple antral follicles. But these follicles grow only up to 6 to 7 mm under the effect of androgen. These small follicles do secret estrogen, and therefore higher estrogen causes a negative feedback for FSH. Low FSH is not enough for follicular maturation and leads to chronic anovulation. But all these follicles do not become dominant due to high LH and/or AMH levels. These follicles which were recruited but not matured undergo atresia, their granulosa cells get converted into theca cells and contribute to stroma. This stroma tries to accommodate itself in the ovarian capsule and therefore starts becoming dense initially and then increases the ovarian volume. Polycystic ovarian morphology has been found to be a better discriminator than ovarian volume between PCOS and control women. 24 Patients having long-standing PCOS and long-standing anovulation have more dense stroma, and this cardinal feature has been shown to be the presence of a bright, highly echogenic stroma on transvaginal ultrasound. 25 In a study by Franks et al, 26 it
is also shown that PCO morphology in normal women is not a morphological variant of normal ovaries, but rather represent a functional entity. Lam and Raine-Fenning have concluded in their study that the current criteria will fail to identify a group of ovulatory, normo-androgenic women still at risk of complications classically associated with PCOS, such as ovarian hyperstimulation syndrome, failed implantation, miscarriage, and hyperinsulinemia. To identify these women, further information, particularly about the ovarian stroma and the degree of vascularization, is required.
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It is known according to two-cell two-hormone theory 28, 29 that LH is responsible for conversion of granulosa cells to theca cells. In the preovulatory phase, this action of LH is seen whenever any follicle is exposed to LH. This means that if a mature follicle is exposed to LH, it leads to conversion of the granulosa cells of this follicle into theca cells and progresses it toward rupture, leading to corpus luteal formation. Instead, if an immature follicle i.e., dominant is exposed to LH, the granulosa cells of this follicle are converted into theca cells, and the follicle is converted into a luteinized unruptured follicle (LUF), which produces progesterone but not as much as corpus luteum, and if a follicle which is still not dominant, may be only an antral follicle, the follicle undergoes atresia and the theca cells of this follicle also contribute to stroma. This shows that detecting the time of natural LH surge or the time when surrogate surge is to be given is the key to success of any assisted reproductive technology (ART). This can be decided by follicle maturity.
Ultrasound Parameters of Follicle with Varying Estrogen Levels
Follicular maturity is assessed biochemically by estrogen level, and on ultrasound by b mode and Doppler assessment of the follicle. Estrogen is responsible for perifollicular vascularity. As seen in the diagrammatic representation of the hormonal variations during the menstrual cycle, the estrogen level gradually starts rising after the 5th day of the menstrual cycle, when the dominant follicle is selected. Increase in perifollicular vascularity of dominant follicle in theca layer starts developing as early as 8th day of the cycle. Fall in perifollicular resistance index (RI) starts 2 days before ovulation. 30 This is the time when the shoot up is seen in the estrogen level. At ovulation when estrogen level has just passed the peak, the RI is the lowest. This means that the RI of the perifollicular vessels can be inversely correlated with the estrogen levels. Increase in peak systolic velocity (PSV) starts 29 hours before ovulation and continues for at least 72 hours after ovulation. 31, 32 This can be explained by the fact that LH is responsible for the influx of blood in the ovary and neoangiogenesis, i.e., essential for the follicular and in turn ovum oxygenation. It is the combined action of estrogen and LH surge that leads to these final circulatory changes before ovulation. Vascular changes at the time of impending ovulation include increased vascularity of the inner wall of the follicle and a coincident surge in blood velocity just prior to eruption. 33 A marked increase in the PSV around the follicle, in the presence of a relatively constant pulsatility index (PI), could be a sign of follicle maturity and impending ovulation. 34 In stimulated cycles the surge is surrogate and, i.e., by hCG. The influx of blood flow surrounding the follicle therefore follows hCG. But it is known that after the peak of LH surge, either natural or surrogate, there is a sudden downfall in the estrogen level, but the rise in the progesterone level is slow and reaches peak only in the mid luteal phase. It is because of this that the uterine artery resistance increases after the LH surge. 35, 36 • High tonic LH levels: Increased ovarian stromal flow on baseline scan • The LH rise with no dominant follicles: Follicular atresia • The LH rise with dominant but not mature follicle (functionally): LUF • Inadequate LH surge with a mature follicle: LUF • The LH surge with a functionally mature follicle: follicle rupture. This means a correct time to use the surrogate LH surge (hCG or GnRh agonist) is of utmost importance. And the ultrasound features which would decide the follicular maturity on the pre-hCG scan are as follows (Fig. 7): • Follicular size of at least 18 mm • Perifollicular vascularity covering 3/4th of the follicular circumference 37 • Perifollicular RI 0.4 to 0.48 21 and PSV > 10 cm/second.
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Follicular RI and PSV are more important in decisionmaking than the size of the follicle. 39 Ovarian flow correlates well with oocyte recovery rates and hence, may be useful in determining the most appropriate time to administer hCG to optimize recovery rate. Oocytes from severely hypoxic follicles are associated with high frequency of abnormalities of organization of chromosomes on metaphase spindle and may lead to segregation disorders and catastrophic mosaics in embryo. 40 Change in these parameters may be of help in deciding the time and number of intrauterine inseminations (IUIs). At the LH surge, the perifollicular PSV is 10 cm/ second. According to certain studies, perifollicular PSV goes as high as 45 cm/second before an hour of ovulation 33 under the effect of rising LH. This means that if the follicle is said to be functionally mature when PSV is 10 cm/second, then, i.e., the time when the LH surge starts, and under the effect of that LH, the perifollicular PSV keeps on rising constantly. Rising PSV with steady low RI suggests that LH surge has already established and the follicle is close to rupture. 34 Steady or decreasing PSV with rising RI suggests that LH surge is either inadequate or has started before the follicle was mature and the follicle is proceeding toward LUF. Therefore, in patients with high pre-hCG perifollicular PSV, early IUI would improve the conception rates. As the endometrium is exposed to the effect of LH on the follicles, the outer margin of the endometrium that was sharp like a pencil line earlier, starts becoming fluffy, before it starts becoming hyperechoic.
Preovulatory Findings and LH
• Fall in perifollicular RI suggests start of LH surge.
• Rise in perifollicular PSV suggests fast rising LH level and impending rupture.
• Rising RI with steady or falling PSV suggests falling or inadequate LH levels and therefore is an indicator of follicle proceeding toward LUF.
• Fluffy outer margins of the endometrium.
ESTROGEN
It is known that the granulosa cells of follicle are responsible for estrogen secretion, and therefore, increasing follicular size is associated with rising estrogen levels. Therefore, the simplest evidence that the estrogen level is rising is the follicular growth. It is worth while mentioning here that FSH is the cause and estrogen is the result of follicular growth. The pre-hCG perifollicular ultrasound parameters mentioned earlier in this article are the parameters of a follicle, i.e., producing sufficient estrogen. Estrogen is produced by the granulosa cells of the follicle, but uterus is the receptor organ for estrogen. Evidently therefore, assessment of the uterus and endometrium should give the clue to adequacy of estrogen levels and in turn of the functional maturity of the follicle. Increasing endometrial thickness and changing endometrial morphology to multilayered correlates with follicular growth and increasing estrogen levels 41 ( Fig. 8) . Cervical mucus (Fig. 9 ) that was earlier assessed on postcoital test can now be seen on ultrasound as fluid in cervical canal and this again is the indicator of estrogen levels comparable to a mature follicle. Therefore in preovulatory period of the menstrual cycle, multilayered endometrium of at least 6 mm, preferably 8 to 10 mm in thickness indicates satisfactory estrogen levels and thin endometrium would be an indicator of low estrogen (inadequate follicular maturity). When the estrogen levels are much higher, the endometrium becomes homogenous and isoechoic instead of multilayered. 41 This is the case in PCOS patients (Fig. 10) .
The endometrial thickness can be used as a guide to estrogen levels on the baseline scan also. For the patients on down regulation for in vitro fertilization (IVF), if the baseline scan shows an endometrial thickness of >3 mm, it is an indicator of inadequate downregulation. 42 This endometrial thickness usually correlates with 30 to 50 pg/mL of estrogen. Though in some cases, it may be because of continuing activity of corpus luteum, this may be confirmed by the corpus luteum with pericorpus luteal low-resistance flow in either ovary.
The vascularity of the endometrium also correlates with the estrogen levels. There are several reports by 32, 36, 43 that agree on the fact that implantation rates can be more correlated to the vascularity of the endometrium rather than the thickness and morphology of the endometrium. Endometrial and subendometrial Zone II -Blood vessels reaching outer hyperechoic endometrial edge.
Zone III -Blood vessels reaching intervening endometrial hypoechoic zone.
Zone IV -Blood vessels reaching endometrial cavity: The central line.
Vascularity of the endometrium before ovulation should reach zone 3 to 4 of the endometrium and should 45 The vessels supplying the endometrium should have an RI of <0.59. Absence of subendometrial and intraendometrial vascularization on the day of hCG appears to be a useful predictor of failure of implantation in IVF, irrespective of morphological appearance. 43 Moreover, it has also been observed that when pregnancy is achieved in the absence of endometrial and subendometrial flow on the day of embryo transfer (ET), more than half of these pregnancies will finish as spontaneous miscarriage. 46 Spiral arteries are branches of uterine arteries and therefore if the resistance in uterine artery is high, evidently resistance in spiral arteries is also high, so assessment of the uterine artery resistance may also be a clue to implantation potential of the endometrium. Just before ovulation the uterine artery resistance rises due to fall in estrogen. hCG administration induces significant increase in the resistance of uterine artery for 48 hours which can affect its evaluation on the day of follicular aspiration/ rupture. 35 Uterine artery resistance is affected by androgen levels as also discussed earlier, and so in patients with hyperandrogenemia (PCOS), uterine artery resistance remains higher throughout the cycle. This may be one of the reasons for implantation failure or early abortions in patient with PCOS. It has been shown in several studies that when uterine artery PI > 3.2, implantation rates are extremely low and ET or IUI should be withheld. [47] [48] [49] If the upper limit of cut for uterine artery PI is established at 3 to 3.3, prediction of nonreceptive uterus has specificity of 96 to 100%, positive predictive value of 88 to 100%, sensitivity of 13 to 35% and negative predictive value of 44 to 56%.
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Correlation of Estrogen with Ultrasound Findings
Thin linear endometrium on baseline scan suggests adequate down regulation and low basal estrogen levels. A follicle of 18 mm was thought to indicate a mature follicle and so adequate estrogen levels. But as discussed earlier, it is not the follicle size but the perifollicular blood flow that decides the functional maturity of the follicle and therefore estrogen production.
Conversion of linear endometrium to multilayered endometrium indicates rising estrogen level to achieve the level of LH surge. Multilayered endometrium, i.e., 8 m or more in thickness indicates adequate estrogen levels for a mature follicle. Homogenization of the multilayered endometrium suggests hyperestrinism as discussed earlier.
SECRETORY PHASE ASSESSMENT
Rupture of the follicle leads to formation of corpus luteum. Corpus luteum is responsible for progesterone production. The functional efficacy of the corpus luteum can be assessed by Doppler by assessing the pericorpus luteal vascularity.
Segmental uterine and ovarian artery perfusion demonstrates a significant correlation with histological and hormonal markers of uterine receptivity and may aid assessment of luteal phase defect. 51 A clear correlation between RI of corpus luteum and plasma progesterone levels has been seen in natural cycle. Resistance index of the corpus luteum can, therefore, be used as an adjunct to plasma progesterone assay as an index of luteal function. 52 A corpus luteum, i.e., functionally normal and produces adequate amount of progesterone shows corpus luteal flow: RI 0.35 to 0.50 and PSV 10 to 15 (Fig. 12) . The receptor organ for progesterone also (like estrogen) is endometrium and its vascular studies can be a reliable clue to adequate progesterone production. Though, endometrial also becomes hyperechoic as a result of progesterone exposure. But soon after rupture of the follicle, the outer margin of the endometrium starts becoming fluffy and blurred. With adequate progesterone levels, that are achieved in the mid-luteal phase, the spiral arteries show RI of 0.48 to 0.52 (low-resistance flow) and uterine artery shows PI of 2.0 to 2.5. This PI is lower than in the preovulatory phase because of smooth muscle relaxing effect of progesterone. Inadequate progesterone production and therefore corpus luteal inadequacy is suggested by high resistance flow in corpus luteal vessels. 52 Whereas, high spiral artery resistance would suggest inadequate response of endometrium to progesterone. This is because of inadequate progesterone receptors in the endometrium or because of local endometrial cause, like endometrial injury or chronic endometritis.
In luteal phase defect because of low progesterone levels, the resistance in the pericorpus luteal vessels is high. Because of low progesterone levels, there is inadequate relaxation of the muscularis of the uterine artery, and therefore, the uterine artery resistance is high along with higher resistance in its branches -the spiral vessels.
Corpus luteal flow and spiral artery flow in normal cycle and luteal phase defect ( 
CORRELATION OF PROGESTERONE TO ULTRASOUND FINDINGS
Blurring of outer margin of multilayered endometrium suggests initiation of progesterone secretion (Fig. 13) . Low resistance flow in corpus luteum, with echogenic endometrium ( Fig. 14) and low resistance endometrial vascularity in mid luteal phase suggests normal luteal phase. High resistance corpus luteal flow suggests corpus luteal inadequacy. High resistance endometrial flow in mid luteal phase suggests either inadequate progesterone levels or inadequate progesterone receptors in endometrium.
CONCLUSION
Ultrasound is an excellent tool for assessment of the menstrual cycle. Hormonal changes occurring day to day during the menstrual cycle reflect as morphological and vascular changes in the ovary and the uterus. Assessing these changes by transvaginal ultrasound and Doppler and correctly interpreting can explain the hormonal basis of these changes. Ultrasound with Doppler can thus be used as the only modality for cycle assessment in patients undergoing ART and may be of help to reduce the cost of the cycle by avoiding certain hormonal assessments and still maintaining close and accurate watch on the hormonal changes occurring during treatment cycle. 
